Healthcare -
Biotechnology - NASDAQ - US
$ 1.32
6.3 %
$ 841 M
Market Cap
-5.0
P/E
GERN - INTEREST INCOME & EXPENSE
Interest Income & Expense GERN - Geron Corporation
18.5 M
LAST VALUE
63.97%
2 YEAR CAGR
0.00%
5 YEAR CAGR
71.93%
10 YEAR CAGR